期刊文献+

维持性血液透析患者血常规、钙、磷、甲状旁腺激素检测指标的调查分析 被引量:2

Analysis for complete blood count,serum calcium,phosphorus and parathormone in patients with maintenance hemodialysis
暂未订购
导出
摘要 目的调查分析维持性血液透析患者的血常规、血清钙、磷及甲状旁腺激素检测指标,为临床治疗提供依据。方法抽取患者透析前空腹静脉血,检测血常规、钙、磷和甲状旁腺激素。采用血细胞分析仪检测血常规各项指标;采用血生化自动分析仪检测血清钙和磷;采用化学发光仪检测甲状旁腺激素。结果 100例男性患者中,血红蛋白(Hb)<135g/L者84例,占84.00%。76例女性患者中,Hb<120g/L者68例,占89.47%。患者血清校正钙浓度平均为(2.26±0.29)mmol/L,达标142例,占80.68%。血清磷平均浓度为(1.69±0.48)mmol/L,达标30例,占17.05%。钙、磷代谢乘积平均为(3.88±1.36)mmol/L,达标37例,占21.02%。结论维持性血液透析患者普遍存在轻度贫血,粒系和血小板基本正常。患者血清钙磷检测结果表现为低钙高磷。贫血和血清钙呈负相关性,与血清磷及钙、磷乘积无相关性。血清钙、磷乘积和甲状旁腺激素具有一定的相关性,甲状旁腺激素异常者的钙磷乘积异常率明显高于甲状旁腺激素正常人群。 Objective To analyze laboratory results of whole blood count,serum calcium,phosphorus and parathormone in patients with maintenance hemodialysis,so as to provide evidence for clinic therapy.Methods Fasting Blood sample was taken from patient before hemodialysis.Whole blood count was analyzed by blood cell analyzer.Serum calcium and phosphorus were analyzed by biochemical analyzer.Parathormone was analyzed by chemiluminescence analyzer.Results Male patients with hemoglobin lower than 135g/L were 84,taking 84.00%.Female patients with hemoglobin lower than 120 g/L were 68,taking 89.47%.Average serum corrected calcium concentration was 2.26±0.29mmol/L,142 patients reached standard,counting for 81.61%.Average serum phosphorus concentration was(1.69 ±0.48)mmol/L,30 patients reached standard,counting for 17.05%.Average product of calcium and phosphorus was 3.88±1.36 mmol/L,37 patients reached standard,counting for 21.02%.Conclusion Patients with maintenance hemodialysis commonly have a mild anemia and normal granulocytes and platelet.Serum calcium concentration is commonly lower,while phosphorus concentration is commonly higher.Anemia has negative correlation with serum calcium and no correlation with phosphorus and product of calcium and phosphorus.Serum product of calcium and phosphorush has correlation with IPTH,and patients with abnormal iPTH concentration has higher abnormal product of calcium and phosphorus compared with patients with normal iPTH concentration.
出处 《检验医学与临床》 CAS 2012年第22期2792-2793,2795,共3页 Laboratory Medicine and Clinic
关键词 维持性血液透析 血常规 甲状旁腺激素 maintenance hemodialysis complete blood count product of calcium-phosphorus parathormone
  • 相关文献

参考文献8

二级参考文献52

  • 1孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:64
  • 2Slatopolsky E.Pathogenesis of secondary hyperparathyroidism.Am J Kidney Dis,1994,23:229 - 236.
  • 3Sherrard DJ.The spectrum of bone disease in end - stage renal failure-An evolving disorder.Kidney Int,1993,43:436 -442.
  • 4Couttenye MM.High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population.Nephrol Dial Transplant,1997,12:2144 - 2150.
  • 5United States Renal Data System.USRDS 1999 Annual Report.Bethesda,National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases,1999.
  • 6Blacher J.Arterial calcifications,arterial stiffness,and cardiovascular risk in end-stage renal disease.Hypertension,2001,38:938-942.
  • 7London GM.Arterial structure and function in end - stage renal disease.Nephrol Dial Transplant,2002,17:1713 - 1724.
  • 8Aparicio M.In advanced renal failure,dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol.Nephron,1993,63:122 - 123.
  • 9Delmez JA.Hyperphosphatemia:Its consequences and treatment in patients with chronic renal disease.Am J Kidney Dis,1992,19:303-317.
  • 10Locatelli F.Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency ,with emphasis on the control of hyperphosph ataemia.Nephrol Dial Transplant,2002,17:723 - 731.

共引文献109

同被引文献26

  • 1劳海燕,杨敏,万波,郑志伟,刘双信,张燕丽.影响维持性血液透析患者血色素达标相关因素分析[J].岭南心血管病杂志,2011,17(S1):168-169. 被引量:1
  • 2何惠,刘基铎,石良招.慢性肾功能衰竭患者贫血与铁原料关系探讨[J].现代中西医结合杂志,2006,15(20):2774-2775. 被引量:4
  • 3Gilmore J.KDOQI clinical practice guidelines and clinical practice recommendations-2006 updates[J].Nephrol Nurs J, 2006,33 (5) : 487-488.
  • 4杨慧.检验指标对慢性肾功能衰竭患者的临床观察[J].中国保健营养(上旬刊),2013,(10):5485.
  • 5Driieke TB,Eckardt KU.Role of secondary hyperparathy- roidism in erythropoietin resistance of chronic renal failure patients[J].Nephrol Dial Transplant, 2002,17 (Suppl 5) : 28- 31.
  • 6Koo HM,Kim CH,Doh FM,et al.The relationship of initial transferrin saturation to cardiovascular parameters and out- comes in patients initiating dialysis [J].PLoS 0ne,2014,9 (2) :e87231.
  • 7Krause A,Neitz S,Magert HJ,et al.LEAP - 1 ,a novel high- ly disulfide-bonded human peptide,exhibits antimicrobial activity[J].FE BS Lett, 2000,480 (2-3) : 147 - 150.
  • 8Park CH,Valore EV,Waring AJ,et al.Hepcidin,a urinary antimicrobial peptide synthesized in the liver[J].J Biol Chem, 2001,276(11) : 7806-7810.
  • 9Malyszko J,Malyszko JS,Pawlak K,et al.Hepcidin,iron status ,and renal function in chronic renal failure,kidney transplantation,and hemodialysis[J].Am J Hematol,2006, 81(11):832-837.
  • 10Shoji S,Inaba M,Tomosugi N,et al.Greater potency of darbepoetin - ot than erythropoietin in suppression of serum hepcidin - 25 and utilization of iron for erythro poiesis in hemodialysis patients[J].Eur J Haematol, 2013, 90 (3) : 237-244.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部